TABLE 4.

Baseline demographics of volunteers screened on panels 1, 2, 3, and 4a

Panel(s) used and site no.Country (n)Gender [% of study population (n)]Mode of transmission [% of study population (n)]Dominant HIV-1 clade(s)
MFUnknownHeterosexualIDUsMSMOtherUnknown
Screened on panels 1 and 2
    Site 1Rwanda (24)0100 (24)100A
    Site 2Zambia (77)40.3 (31)59.7 (46)100C
    All sitesAll (101)30.7 (31)69.3 (70)100A, C
Screened on panel 3
    Site 1Australia (81)97.5 (79)2.5 (2)96.3 (78)2.7 (3)B
    Site 2Rwanda (83)53.7 (44)46.3 (38)100A
    Site 3Uganda (189)23.3 (44)76.7 (145)100A, D
    Site 4United Kingdom (58)94.8 (55)5.2 (3)5.2 (3)1.7 (1)91.4 (53)1.7 (1)B
    Site 5Zambia (52)34.6 (18)65.4 (34)100C
    All sitesAll (463)51.8 (240)48.2 (223)70.63 (327)<1 (1)28.2 (131)<1 (4)A, B, C, D
Screened on panel 4
    Site 1Rwanda (100)49 (49)51 (51)100A
    Site 2Uganda (58)18.96 (11)81.04 (47)100A, D
    Site 3United Kingdom (138)34.06 (47)3.6 (5)62.32 (86)5.8 (8)27.53 (38)66.67 (92)B
    Site 4United States (91)0100 (91)47.25 (43)16.48 (15)36.27 (33)B
    Site 5Zambia (76)34.2 (26)65.8 (50)100C
    Site 6Thailand (200)56 (112)44 (88)62 (124)23 (46)11 (22)4 (8)CRF01_AE, B
    Site 7Ivory Coast (200)40.5 (81)59.5 (119)100CRF02_AG
    Site 8South Africa (170)7.1 (12)89.9 (107)30 (51)100C
    Site 9Kenya (201)14.93 (30)85.07 (171)100A
    All sitesAll (1,234)29.82 (368)59.08 (729)11.1 (137)79.42 (980)4.94 (61)4.86 (60)3.32 (41)7.46 (92)A,B,C, D, CRF01_AE, and CRF02_AG
Screened on panels 1, 2, 3, and 4
    All sitesAll (1,798)35.54 (639)56.84 (1,022)7.62 (137)78.31 (1,408)3.45 (62)10.62 (191)2.50 (45)5.12 (92)A, B,C, D, CRF01_AE, and CRF02_AG
  • a M, male; F, female; MSM, men who have sex with men; IDU, intravenous drug users.